Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis

Stopped early · Not applicable

Conditions studied: Epistaxis

In brief

Epistaxis is a common problem among people of all ages and backgrounds. However, occasionally epistaxis can be severe enough to require emergency room admission. Among the treatment options for epistaxis, nasal packing is the most common approach. This approach requires a return visit to the clinic for removal of the packing. Additionally, there is a great deal of pain during the insertion and removal of this packing. This study aims to justify the further investigation of thrombin as a potential treatment approach for these patients. Thrombin could provide a treatment approach that reduces pain and eliminates the need for a return visit to the clinic.

Key facts

Study ID

NCT00814333

Run by

University of Kansas Medical Center

People needed

1

Starts

2008-12-01

Expected to finish

2011-08-01

Last updated by the study team

2016-01-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• English speaking adults that have failed first line therapy for anterior epistaxis in the ER or the hospital

You may not qualify if…

• Non-english speaking patients
• Patients with bleeding disorders
• Known pregnant women or women that think they may be pregnant
• Patients with a know presence of antibodies to bovine thrombin preparations
• Patients that currently have or are known to have a history of systemic skin condition or rash such as eczema or psoriasis
• Patients found to have posterior epistaxis
• Patients requiring a surrogate for medical decisions

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.